Atlas Venture is a leading biotech venture capital firm.  Atlas companies are custom built to realize their scientific and business potential.

DISCOVER: Identifying true innovation from high-impact science.

DERISK: Proving and maturing the science and technology to guide clinical translation

SHAPE: Crafting the right business model for each opportunity.

STRENGTHEN: Rolling up our sleeves to position our companies for successful drug development and exits in all market environments.

TypeInvestor
HQCambridge, MA, US
Founded1984
Websiteatlasventure.com
Cybersecurity ratingAMore
Atlas Venture was founded in 1984 and is headquartered in Cambridge, MA, US
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Atlas Venture

Kevin Bitterman

Kevin Bitterman

Partner
Bruce Booth

Bruce Booth

Partner
Jason Rhodes

Jason Rhodes

Partner
Jean-Francois Formela

Jean-Francois Formela

Partner
David Grayzel

David Grayzel

Partner
Michael Gladstone

Michael Gladstone

Partner
Show more

Atlas Venture Office Locations

Atlas Venture has an office in Cambridge
Cambridge, MA, US (HQ)
400 Technology Square, 400 Technology Square
Show all (1)

Atlas Venture Investment Portfolio

Stage Distribution

20002021

Top Sectors Distribution

19992021

Round Size Distribution

20002021
Show more

Atlas Venture News and Updates

K36 Therapeutics Launches with $30 Million Series A Financing from F-Prime Capital and Atlas Venture with Eight Roads Ventures

CAMBRIDGE, Mass., Dec. 9, 2021 /PRNewswire/ -- K36 Therapeutics, Inc. ("K36"), a privately held biotechnology company developing breakthrough therapies for the unmet medical needs of cancer patients, announced today its $30 million Series A financing co-led by F-Prime Capital and Atlas...

Akrevia Therapeutics Launches with $30M Series A Financing Led by F-Prime Capital Partners and Atlas Venture

CAMBRIDGE, Mass., Sept. 27, 2018 /PRNewswire/ -- Akrevia Therapeutics, a privately-held biopharmaceutical company focused on developing highly-potent, tumor-targeted immuno-oncology therapeutics, today announced the closing of a $30 million Series A financing led by F-Prime Capital...

Atlas Venture wraps up 11th fund at $350 mln

Cambridge, Massachusetts-based Atlas Venture, an early-stage venture firm, has closed its oversubscribed 11th fund at $350 million. Altas Ventures invests in biotech startups.

Atlas Venture Online and Social Media Presence

Embed Graph

Atlas Venture Blogs

Out On The (Cutting) Edge: How The Tools Of Extreme Survival Can Help Build A Biotech Company

A couple of years ago, my husband returned from a business trip with a random gift for me. He was running through an airport giftshop when something caught his eye: a book with the title “Deep Survival.” I raised an eyebrow as he handed it to me. I am not exactly an adventure sports type.Read More »…

Navigating Change: Observations from the Talent side of Professional Change

Like many of you, I’m a consumer of biotech industry news. Multiple times of day I scour BioCentury, STAT, Endpoints, Fierce Biotech and LinkedIn to track the scientific landscape, company events, and people updates. During the height of the pandemic, these information sources fueled my confidence t…

Take the Hors D’oeuvres When They’re Passed And Other Life Lessons From An “Old” CEO

Our company recently launched out of stealth with a trade media campaign in the usual outlets, which felt great until one article title included an unfortunate grammatical error. By Natalie Holles, CEO of Third Harmonic Bio, as part of the From The Trenches feature of LifeSciVC. Read more. The post …

To spend less on health care, invest more in medicines

The conventional wisdom that we need to reduce spending on prescription drugs is all wrong. In an ideal health care system, we’d spend more on drugs, not less. Read more. The post To spend less on health care, invest more in medicines appeared first on Atlas Venture.

Biotech’s January Chill: Big Drop In New Startups

While the pace of startup formation in biotech has been accelerating over the past decade, early signs suggest the malaise in the markets is finding its way back into the venture creation ecosystem. Read more. The post Biotech’s January Chill: Big Drop In New Startups appeared first on Atlas Venture…

Collaborating with Patient Advocacy Groups to Advance Rare Disease Awareness and Support

Over my many years in the biopharma industry, working across disease areas, including orphan indications, I have learned that to impact patients’ lives credibly and meaningfully, we must raise awareness about the conditions we are attempting to treat. One of the most effective ways is to engage with…
Show more

Atlas Venture Frequently Asked Questions

  • When was Atlas Venture founded?

    Atlas Venture was founded in 1984.

  • Who are Atlas Venture key executives?

    Atlas Venture's key executives are Kevin Bitterman, Bruce Booth and Jason Rhodes.

  • Where is Atlas Venture headquarters?

    Atlas Venture headquarters is located at 400 Technology Square, 400 Technology Square, Cambridge.

  • Where are Atlas Venture offices?

    Atlas Venture has an office in Cambridge.

  • How many offices does Atlas Venture have?

    Atlas Venture has 1 office.